
Iyi ngingo itanga incamake yuzuye ya ubuvuzi bugamije gutanga imiti ya kanseri, gucukumbura uburyo bwayo, inyungu, imbogamizi, nicyerekezo kizaza. Twinjiye muburyo butandukanye, harimo nanotehnologiya, antibody-ibiyobyabwenge bya conjugate, hamwe nubuvuzi bwa gene, dusuzuma ibyifuzo byabo byubuvuzi nubushakashatsi burimo gukorwa. Wige ibyiza byo kuvura bigereranijwe ugereranije na chimiotherapie gakondo nimbaraga zikomeje kunoza imikorere no kugabanya ingaruka mbi.
Nanotehnologiya igira uruhare runini muri ubuvuzi bugamije gutanga imiti ya kanseri. Nanoparticles, bitewe nubunini bwayo nubushobozi bwo kwinjira mu ngingo, irashobora gutanga imiti ya chimiotherapeutique mu ngirabuzimafatizo y'ibibyimba, bikagabanya guhura n'ingingo nziza. Ubwoko butandukanye bwa nanoparticles, harimo liposomes, polymeric nanoparticles, hamwe na nanoparticles ya organic organique, burimo gushakishwa kubushobozi bwabo mukuzamura imikorere yibiyobyabwenge no kugabanya uburozi. Kurugero, liposomal doxorubicin (Doxil) nuburyo bwemewe nubuvuzi bugamije gutanga imiti igabanya umutima ugereranije na doxorubicine isanzwe. Ubushakashatsi bukomeje kunonosora igishushanyo cya nanoparticle kugirango tumenye neza ibibyimba no kurekura ibiyobyabwenge. Ikigo cy’ubushakashatsi cya kanseri ya Shandong Baofa kigira uruhare runini mu gushakisha iterambere rigezweho muri uru rwego.
ADCs yerekana izindi ngamba zingenzi muri ubuvuzi bugamije gutanga imiti ya kanseri. Iyi miti ivura igizwe numuti wa cytotoxic uhujwe na antibody ya monoclonal yibasira cyane kanseri ya kanseri. Ubu buryo buteganya ko imiti igezwa ku ngirabuzimafatizo za kanseri, igabanya ingaruka zitari nziza kandi igateza imbere icyerekezo cyo kuvura. Ingero za ADC zemewe zirimo trastuzumab emtansine (Kadcyla) kuri kanseri y'ibere ya HER2 nziza na brentuximab vedotine (Adcetris) ya lymphoma ya Hodgkin. Ubushakashatsi bukomeje bwibanda ku kunoza antibody igamije umwihariko no guteza imbere imitwaro ya cytotoxic.
Ubuvuzi bwa Gene butanga inzira itanga icyizere kuri ubuvuzi bugamije gutanga imiti ya kanseri. Ubu buryo bukubiyemo guhindura ingirabuzimafatizo ziri mu ngirabuzimafatizo za kanseri kugira ngo zibuze gukura kw'ibibyimba cyangwa kongera ubushobozi bw'umubiri bwo kurwanya kanseri. Indwara ya virusi ikoreshwa mugutanga ingirabuzimafatizo zo kuvura ingirabuzimafatizo. Ubundi bushakashatsi bugaragaza uburyo bwo guhindura gene nka CRISPR-Cas9 kugirango ihindurwe neza kandi ikore neza.
Sisitemu yo gutanga imiti igamije gutanga inyungu nyinshi kurenza imiti isanzwe, harimo kunoza imikorere, kugabanya uburozi, no kwihanganira abarwayi. Icyakora, imbogamizi ziracyafite, harimo guteza imbere kurwanya ibiyobyabwenge, gukenera gutera ibibyimba neza, hamwe n’igiciro kinini cy’ubuvuzi.
| Uburyo | Ibyiza |
|---|---|
| Gutanga Nanoparticle | Kunoza imikorere yibiyobyabwenge, kugabanya uburozi |
| Antibody-Ibiyobyabwenge | Gutanga imiti yatoranijwe, indangagaciro yo kuvura |
| Ubuvuzi bwa Gene | Ibishoboka byo kurwanya kanseri igihe kirekire |
Imbonerahamwe 1: Kugereranya Uburyo bwo Gutanga Ibiyobyabwenge Biteganijwe
Ubushakashatsi burimo kwibanda ku gukemura imbogamizi za sisitemu zo gutanga ibiyobyabwenge bigezweho no guteza imbere uburyo bushya. Ibi birimo kunoza ibiyobyabwenge byibanda, kongera ibiyobyabwenge, no gutsinda ibiyobyabwenge. Guhuriza hamwe ingamba nyinshi zigamije, uburyo bwihariye bwo kuvura, hamwe no guteza imbere uburyo bwo gutanga ibiyobyabwenge byubwenge biteganijwe kurushaho kurushaho kunoza imikorere n’umutekano bya ubuvuzi bugamije gutanga imiti ya kanseri. Ubundi bushakashatsi ku bigo nka Shandong Baofa Ikigo Cyubushakashatsi Kanseri ni ngombwa mu guteza imbere uru rwego.
Inshingano: Aya makuru agamije intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu buzima kubibazo byose byubuzima cyangwa mbere yo gufata ibyemezo byose bijyanye nubuzima bwawe cyangwa kwivuza.
Reba: (Shyiramo imirongo yatanzwe hano, werekana ubushakashatsi bwihariye nibisohokayandikiro bishyigikira amakuru yatanzwe. Koresha uburyo buhoraho.)